Best Stocks Under $3 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Ur Energy NYSEAMERICAN:URG$2.10 +0.39 (+22.81%) Closing price 04:10 PM EasternExtended Trading$2.17 +0.07 (+3.57%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$679.44 millionConsensus RatingBuyConsensus Price Target$2.57 (+22.2% Upside)Volume44.10 million sharesAverage Volume8.69 million sharesToday's Range$1.73▼$2.15 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. iBio NASDAQ:IBIO$1.76 -0.13 (-6.88%) Closing price 04:00 PM EasternExtended Trading$1.78 +0.01 (+0.85%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBioMarket Capitalization$93.89 millionConsensus RatingBuyConsensus Price Target$4.75 (+169.9% Upside)Volume1.14 million sharesAverage Volume769,551 sharesToday's Range$1.71▼$1.923. Inhibikase Therapeutics NASDAQ:IKT$1.70 -0.01 (-0.58%) Closing price 04:00 PM EasternExtended Trading$1.72 +0.02 (+1.41%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase TherapeuticsMarket Capitalization$225.78 millionConsensus RatingBuyConsensus Price Target$5.50 (+223.5% Upside)Volume526,412 sharesAverage Volume672,119 sharesToday's Range$1.66▼$1.734. Stereotaxis NYSEAMERICAN:STXS$1.97 +0.03 (+1.55%) Closing price 04:10 PM EasternExtended Trading$1.96 0.00 (-0.25%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about StereotaxisMarket Capitalization$189.61 millionConsensus RatingBuyConsensus Price Target$3.88 (+96.7% Upside)Volume253,515 sharesAverage Volume359,537 sharesToday's Range$1.92▼$2.005. Peraso NASDAQ:PRSO$1.09 -0.02 (-1.80%) Closing price 04:00 PM EasternExtended Trading$1.08 -0.01 (-0.92%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Peraso Inc, a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules. More about PerasoMarket Capitalization$16.36 millionConsensus RatingBuyConsensus Price Target$3.00 (+175.2% Upside)Volume616,082 sharesAverage Volume3.23 million sharesToday's Range$1.09▼$1.136. Ovid Therapeutics NASDAQ:OVID$2.40 -0.16 (-6.25%) Closing price 04:00 PM EasternExtended Trading$2.46 +0.06 (+2.50%) As of 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid TherapeuticsMarket Capitalization$477.80 millionConsensus RatingModerate BuyConsensus Price Target$5.13 (+113.5% Upside)Volume1.41 million sharesAverage Volume1.71 million sharesToday's Range$2.37▼$2.637. Autolus Therapeutics NASDAQ:AUTL$1.75 -0.09 (-4.89%) Closing price 04:00 PM EasternExtended Trading$1.78 +0.03 (+1.71%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus TherapeuticsMarket Capitalization$489.70 millionConsensus RatingModerate BuyConsensus Price Target$8.75 (+400.0% Upside)Volume1.17 million sharesAverage Volume1.67 million sharesToday's Range$1.75▼$1.848. Palisade Bio NASDAQ:PALI$1.86 -0.22 (-10.58%) Closing price 04:00 PM EasternExtended Trading$1.91 +0.05 (+2.58%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade BioMarket Capitalization$361.05 millionConsensus RatingModerate BuyConsensus Price Target$10.20 (+448.4% Upside)Volume5.18 million sharesAverage Volume2.61 million sharesToday's Range$1.85▼$2.149. Context Therapeutics NASDAQ:CNTX$2.42 -0.37 (-13.26%) Closing price 04:00 PM EasternExtended Trading$2.47 +0.05 (+2.07%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$256.34 millionConsensus RatingModerate BuyConsensus Price Target$6.60 (+172.7% Upside)Volume538,203 sharesAverage Volume618,567 sharesToday's Range$2.42▼$2.8010. Real Brokerage NASDAQ:REAX$1.72 -0.10 (-5.49%) Closing price 04:00 PM EasternExtended Trading$1.72 0.00 (-0.29%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Real Brokerage Inc, together with its subsidiaries, operates as a real estate technology company in the United States and Canada. More about Real BrokerageMarket Capitalization$388.57 millionConsensus RatingModerate BuyConsensus Price Target$5.69 (+230.7% Upside)Volume4.02 million sharesAverage Volume3.96 million sharesToday's Range$1.70▼$1.8111. Connect Biopharma NASDAQ:CNTB$2.15 -0.19 (-8.12%) Closing price 04:00 PM EasternExtended Trading$2.42 +0.27 (+12.74%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. More about Connect BiopharmaMarket Capitalization$147.34 millionConsensus RatingModerate BuyConsensus Price Target$7.20 (+234.9% Upside)Volume224,899 sharesAverage Volume164,370 sharesToday's Range$2.15▼$2.3612. Compass Therapeutics NASDAQ:CMPX$2.08 -0.14 (-6.31%) Closing price 04:00 PM EasternExtended Trading$2.07 -0.01 (-0.29%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass TherapeuticsMarket Capitalization$399.80 millionConsensus RatingModerate BuyConsensus Price Target$12.91 (+520.6% Upside)Volume5.18 million sharesAverage Volume5.66 million sharesToday's Range$2.06▼$2.1713. Nouveau Monde Graphite NYSE:NMG$1.92 +0.02 (+0.79%) Closing price 03:59 PM EasternExtended Trading$1.94 +0.01 (+0.78%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde GraphiteMarket Capitalization$307.18 millionConsensus RatingModerate BuyConsensus Price Target$4.67 (+142.4% Upside)Volume686,022 sharesAverage Volume1.18 million sharesToday's Range$1.90▼$1.9614. MediciNova NASDAQ:MNOV$1.34 -0.03 (-2.19%) Closing price 04:00 PM EasternExtended Trading$1.35 +0.01 (+0.75%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MediciNova, Inc, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. More about MediciNovaMarket Capitalization$67.43 millionConsensus RatingModerate BuyConsensus Price Target$7.50 (+459.7% Upside)Volume9,476 sharesAverage Volume25,482 sharesToday's Range$1.34▼$1.3615. Tenaya Therapeutics NASDAQ:TNYA$0.79 -0.08 (-9.20%) Closing price 04:00 PM EasternExtended Trading$0.84 +0.05 (+5.82%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya TherapeuticsMarket Capitalization$188.79 millionConsensus RatingModerate BuyConsensus Price Target$4.00 (+406.3% Upside)Volume5.61 million sharesAverage Volume4.89 million sharesToday's Range$0.79▼$0.8916. Nano-X Imaging NASDAQ:NNOX$1.92 -0.03 (-1.54%) Closing price 04:00 PM EasternExtended Trading$1.94 +0.02 (+1.09%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. More about Nano-X ImagingMarket Capitalization$135.70 millionConsensus RatingModerate BuyConsensus Price Target$5.00 (+160.4% Upside)Volume1.08 million sharesAverage Volume1.22 million sharesToday's Range$1.90▼$1.9817. High Tide NASDAQ:HITI$2.39 -0.04 (-1.65%) Closing price 04:00 PM EasternExtended Trading$2.40 +0.01 (+0.54%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.High Tide Inc engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Retail and Wholesale segments. More about High TideMarket Capitalization$213.59 millionConsensus RatingModerate BuyConsensus Price Target$6.13 (+156.3% Upside)Volume359,517 sharesAverage Volume346,540 sharesToday's Range$2.37▼$2.4418. Nkarta NASDAQ:NKTX$2.91 -0.23 (-7.32%) Closing price 04:00 PM EasternExtended Trading$2.94 +0.03 (+1.20%) As of 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about NkartaMarket Capitalization$224.65 millionConsensus RatingModerate BuyConsensus Price Target$10.75 (+269.4% Upside)Volume468,308 sharesAverage Volume633,975 sharesToday's Range$2.90▼$3.1519. Metagenomi NASDAQ:MGX$1.33 +0.02 (+1.53%) Closing price 04:00 PM EasternExtended Trading$1.37 +0.04 (+3.01%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Metagenomi, Inc, a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. More about MetagenomiMarket Capitalization$49.32 millionConsensus RatingModerate BuyConsensus Price Target$9.00 (+576.7% Upside)Volume202,871 sharesAverage Volume186,078 sharesToday's Range$1.29▼$1.3620. Compugen NASDAQ:CGEN$2.26 -0.20 (-8.13%) Closing price 04:00 PM EasternExtended Trading$2.29 +0.03 (+1.28%) As of 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. More about CompugenMarket Capitalization$232.60 millionP/E Ratio6.11Consensus RatingModerate BuyConsensus Price Target$5.00 (+121.2% Upside)Volume1.12 million sharesAverage Volume530,191 shares21. enCore Energy NASDAQ:EU$1.74 +0.10 (+6.10%) Closing price 04:00 PM EasternExtended Trading$1.77 +0.03 (+1.95%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$318.54 millionConsensus RatingModerate BuyConsensus Price Target$3.83 (+120.3% Upside)Volume5.90 million sharesAverage Volume2.86 million sharesToday's Range$1.63▼$1.7922. Senti Biosciences NASDAQ:SNTI$0.98 +0.00 (+0.36%) Closing price 04:00 PM EasternExtended Trading$1.01 +0.03 (+2.87%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Senti Biosciences, Inc operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. More about Senti BiosciencesMarket Capitalization$30.53 millionConsensus RatingModerate BuyConsensus Price Target$8.75 (+789.4% Upside)Volume263,462 sharesAverage Volume191,046 sharesToday's Range$0.97▼$1.0523. DeFi Technologies NASDAQ:DEFT$0.57 -0.05 (-7.81%) Closing price 04:00 PM EasternExtended Trading$0.59 +0.01 (+2.37%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DeFi Technologies, Inc engages in the provision of investment services. It plans to acquire equity, debt, or other securities of publicly traded or private companies or other entities. More about DeFi TechnologiesMarket Capitalization$241.37 millionP/E Ratio5.73Consensus RatingModerate BuyConsensus Price Target$2.00 (+248.8% Upside)Volume5.69 million sharesAverage Volume4.39 million shares24. American Resources NASDAQ:AREC$2.74 +0.16 (+6.20%) Closing price 04:00 PM EasternExtended Trading$2.74 +0.00 (+0.04%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.American Resources Corporation, together with its subsidiaries, extracts, processes, transports, and sells metallurgical coal to the steel and industrial industries. More about American ResourcesMarket Capitalization$275.99 millionConsensus RatingModerate BuyConsensus Price Target$6.00 (+119.0% Upside)Volume4.46 million sharesAverage Volume3.35 million sharesToday's Range$2.53▼$2.8225. Biomea Fusion NASDAQ:BMEA$1.37 -0.02 (-1.44%) Closing price 04:00 PM EasternExtended Trading$1.40 +0.03 (+2.48%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea FusionMarket Capitalization$100.50 millionConsensus RatingModerate BuyConsensus Price Target$8.29 (+504.8% Upside)Volume883,338 sharesAverage Volume1.07 million sharesToday's Range$1.35▼$1.44 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Marvell Stock Soars on NVIDIA's Trillion-Dollar Nod Dollar General Signals Reversal With 60% Rebound Potential Kohl's Stock Soars After Better-Than-Feared Quarter Credo Technologies Paved a Path to a $300 Price Point MGM Buyout: The House Doesn't Always Win Alphabet's $80 Billion Offering: Worrisome Dilution or AI Confidence? FirstCash Turns Pawn Into a Growth Machine HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
